drugset / Trial / NCT00319787
Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine if the addition of ZD1839 Iressa™ to standard treatment with Casodex® (bicalutamide) for locally advanced prostate cancer can detect a difference in the rate of decrease of prostate specific antigen (PSA) levels.
Timeline
- Start
- 2003-12
- Primary completion
- —
- Completion
- 2006-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gefitinib | Small molecule | — | — |
Indications
No indication recorded.